ANALYSING OF ANTIBIOTIC USE IN THE TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN CHILDREN AT CAN THO CHILDREN'S HOSPITAL IN 2024
Main Article Content
Abstract
Background: In recent years, the rate of pneumonia has tended to increase, especially in children. Pneumonia is not only the leading cause of death in this group of diseases, but also higher than the death rate due to AIDS and malaria combined. Objectives: To survey the situation and analyze the rationality of antibiotics used in the treatment of community-acquired pneumonia in children at Can Tho Children's Hospital in 2024. Matherials and methods: Cross-sectional descriptive study, conducted on 301 inpatient medical records of children treated for pneumonia at the Department of Respiratory Medicine, using antibiotics and having a discharge date between January 1, 2024 and June 30, 2024. Data were processed and analyzed using Excel 2016 and SPSS 26.0 software. Results: Among 301 medical records, the group of children aged 1-5 years old had the highest rate of disease (42.5%), followed by the group aged 2 to under 12 months old (39.9%). Of which, the number of severe pneumonia cases accounted for 12%, the number of cases treated with concomitant diseases was 16.6%. Regarding the use of antibiotics, the 3rd generation Cephalosporin group was used most with 57.8%, of which Cefotaxime was most commonly used with 51.8%. The majority of patients were treated with monotherapy (66.4%), with a common treatment duration of 6-10 days (63.5%). Based on the Criteria for analyzing the rationality of antibiotic use, the selection of appropriate antibiotics was 92.4%, the appropriate antibiotic dosage was 87.7%, and the appropriate dose rate was 97%. The treatment results showed that 99% of patients were discharged in a state of recovery and improvement. The survey results showed that the rate of appropriate antibiotic selection was 81.4% and 18.6% of cases still did not meet the criteria for rationality. Conclusions: Although the rate of appropriate antibiotic use was 81.4%, there are still some limitations that need to be overcome to improve treatment effectiveness. This requires close coordination between doctors and health professionals in optimizing treatment regimens, improving the use of antibiotics more safely, rationally and effectively, contributing to reducing the risk of drug resistance and improving the quality of child health care.
Article Details
Keywords
Community-acquired pneumonia, children, antibiotics, Can Tho Children's Hospital
References

2. Bộ Y tế. Quyết định số 3312/QĐ-BYT. Quyết định về việc ban hành tài liệu chuyên môn hướng dẫn chẩn đoán và điều trị một số bệnh thường gặp ở trẻ em. 2015.

3. Nguyễn Trần Kim Ngọc. Tình hình sử dụng kháng sinh kinh nghiệm trong điều trị viêm phổi cộng đồng ở trẻ em từ 2 tháng đến 5 tuổi tại bệnh viện Nhi Đồng Cần Thơ 2023. Tạp chí Y Dược học Cần Thơ. 2024;75:158-165.

4. Nguyễn Đặng Bảo Trân. Nghiên cứu tình hình sử dụng kháng sinh trong điều trị viêm phổi cộng đồng cho trẻ em từ 2 tháng đến 5 tuổi tại Khoa nhi, bệnh viện Đa khoa Trung ương Quảng Nam. Tạp chí Y Dược học Cần Thơ. 2024;74:195-202.

5. Nguyễn Thị Trúc Linh. Thực trạng sử dụng thuốc kháng sinh trong điều trị viêm phổi cộng đồng ở trẻ em dưới 5 tuổi tại bệnh viện Nhi Đồng Cần Thơ năm 2019-2020. Tạp chí Y Dược học Cần Thơ. 2021;37:41-47.

6. Dustin K. Community-Acquired Pneumonia in Children: Rapid Evidence Review. 2021;104(6): 618-625.

7. Kinimi L, Shinde, SS, Rao NM. Management of Children with Community-acquired Pneumonia: A Review of Literature. 2020;2(3):99-106.

8. Yan NL. Infection and co-infection patterns of community-acquired pneumonia in patients of different ages in China from 2009 to 2020: a national surveillance study. 2023;4(5):330-339.
